---
title: MannLabs @2025
description: The Year 2025 in Review
---

## Overview

2025 has been an exceptional year for the Mann Lab, with major
publications in Nature (3), Nature Biotechnology, Nature Genetics,
Nature Protocols, Nature Communications, Cancer Cell, Cell, Cell
Systems, EMBO Molecular Medicine, and Molecular Cell among others. Our
work continues to advance mass spectrometry-based proteomics technology
while translating these capabilities into clinical and biological
applications.

| Last/Senior Author Papers (Published) | 18+ |
| ------------------------------------- | --- |
| Preprints (bioRxiv/medRxiv)           | 9+  |
| Nature family papers                  | 7   |
| Major Collaborations                  | 6+  |

## Technology Advances

### Proteomics Methods

- **SPEC (Solid-Phase Extraction Capture)** Heymann T, Oliinyk D,
  Henneberg L, et al. _bioRxiv 2025.05.31.657165_ Nanoliter-volume
  workflow for fast, robust and ultrasensitive proteomics enabling
  unprecedented sensitivity from minimal sample input.

- **PCA-N Workflow for Plasma Proteomics** Albrecht V, Müller-Reif JB,
  Brennsteiner V, Mann M _Mol Cell Proteomics. 2025 Nov;24(11):101071_
  Simplified perchloric acid workflow enabling deep plasma proteomics
  at population scale with \>10,000 samples per day throughput.

- **nanoPhos -- Spatial Phosphoproteomics** Oliinyk D, Heymann T,
  Henneberg L, et al. _bioRxiv 2025.05.29.656770_ Ultra-sensitive
  cell-type resolved spatial phosphoproteomics enabling signaling
  analysis at single-cell resolution in tissues.

- **PASEF Workflow Protocol** Skowronek P, Wallmann G, Wahle M,
  Willems S, Mann M _Nat Protoc. 2025 Jun;20(6):1700-1729_ Accessible
  step-by-step protocol for high-sensitivity proteomics using parallel
  accumulation-serial fragmentation.

- **Stellar MS for Biomarker Translation** Wahle M, Remes PM, Albrecht
  V, et al., Mann M _Mol Cell Proteomics. 2025 Sep;24(9):101050_ Novel
  hybrid high-speed mass spectrometer enables rapid translation from
  biomarker candidates to targeted clinical tests using 15N-labeled
  proteins.

- **Pre-Analytical Drivers of Bias in Plasma Proteomics** Korff K,
  Müller-Reif JB, et al., Mann M, Geyer PE _EMBO Mol Med. 2025
  Nov;17(11):3174-3196_ Systematic evaluation of plasma proteomics
  workflows reveals susceptibility to cellular contamination and
  provides framework for quality control.

## Bioinformatics & Software

- **AlphaDIA -- Transfer Learning for DIA** Wallmann G, Skowronek P,
  Brennsteiner V, et al., Mann M _Nat Biotechnol. 2025 Oct 21_
  End-to-end transfer learning enabling feature-free proteomics with
  dramatically improved identification rates.

- **ADAPT-MS -- Adaptive Clinical Diagnostics** Müller-Reif JB,
  Albrecht V, Brennsteiner V, et al., Wewer Albrechtsen NJ, Mann M _In
  press at Nature Communications (medRxiv 2025.05.02.25326901)_
  Framework enabling direct diagnostic interpretation of
  discovery-mode proteomics data for personalized testing.

- **scPortrait -- Single-Cell Image Integration** Mädler SC, Schmacke
  NA, Palma A, et al., Theis FJ, Mann M _bioRxiv 2025.09.22.677590_
  Software package for generation, storage and application of
  single-cell image datasets enabling multimodal analysis.

- **Tree-based Proteoform Quantification** Ammar C, Thielert M, Weiss
  CAM, et al., Mann M _bioRxiv 2025.03.06.641844_ Novel computational
  approach to infer proteoform regulation from bottom-up proteomics
  data.

- **AI Laboratory Agents** Skowronek P, Nawalgaria A, Mann M _Mol Syst
  Biol. 2025 Dec_ Multimodal AI agents for capturing and sharing tacit
  laboratory practice through video, speech, and text analysis.

## High-Throughput Applications

### Clinical & Population Proteomics

- **Plasma Proteome in Children and Adolescents** Niu L, Stinson SE,
  Holm LA, et al., Mann M _Nat Genet. 2025 Feb 19_ Comprehensive
  proteomic profiling of 2,147 children revealing associations with
  age, sex, puberty, BMI, and genetics.

- **MS-based Proteomics: Single Cells to Clinical Applications** Guo
  T, Steen JA, Mann M _Nature. 2025 Feb;638(8052):901-911_ Major
  review article charting the path from technological advances to
  clinical implementation of proteomics.

- **Ontology-guided Clustering for Rare Pediatric Disorders** Itang
  ECM, Albrecht V, et al., Mann M, Pangratz-Fuehrer S, Mueller-Reif JB
  _EMBO Mol Med. 2025 Jul;17(7):1842-1867_ Framework integrating
  clinical ontologies with proteomics enables analysis of 394 rare
  pediatric conditions from 1,140 patients.

### Disease Biology & Spatial Proteomics

- **Alpha-1 Antitrypsin Deficiency -- Liver Disease** Rosenberger FA,
  Mädler SC, et al., Mann M _Nature. 2025 Apr 16_ Deep Visual
  Proteomics reveals why some patients with the hereditary liver
  disease remain healthy while others develop severe pathology.

- **Liver Zonation and Fibrosis** Weiss CAM, Brown LA, Miranda L, et
  al., Rosenberger FA, Mann M _bioRxiv 2025.04.13.648568_ Single cell
  spatial proteomics maps human hepatocyte zonation patterns and their
  vulnerability to fibrosis.

- **Colon Organoid Models** Post F, Hausmann A, et al., Mann M _Cell
  Syst. 2025 Sep 17;16(9):101396_ DVP reveals in vivo-like phenotype
  upon xenotransplantation of human colon organoids.

- **Pancreatic Islet Cell Diversity** Thielert M, Villalba A, et al.,
  Mann M, Scharfmann R _Commun Biol. 2025 Oct 17;8(1):1483_ Cell
  type-resolved proteomics and phosphoproteomics decode adult murine
  pancreatic islet cell diversity.

- **Signet Ring Cell Carcinoma** Kabatnik S, Zheng X, et al., Mann M
  _NPJ Precis Oncol. 2025 Feb 5;9(1):37_ DNA replication stress
  identified as a hallmark of signet ring cell carcinoma through DVP.

- **Tumor-Immune Crosstalk** Zheng X, Mund A, Mann M _Mol Cell. 2025
  Mar 6;85(5):1008-1023.e7_ Deciphering functional tumor-immune
  crosstalk through highly multiplexed imaging and deep visual
  proteomics.

## Major Collaborations

### Ovarian Cancer -- Ernst Lengyel (U. Chicago)

- **Borderline Ovarian Tumor Progression (LGSC)** Schweizer L, Kenny
  HA, et al., Mann M, Lengyel E _Cancer Cell. 2025 Jun 20_ Spatial
  proteo-transcriptomics reveals molecular landscape of borderline
  ovarian tumors. Identified 16 drug targets; combination therapy
  achieved significant tumor reduction.

- **Early Ovarian Cancer Mechanisms (HGSC)** Metousis A, Kenny HA,
  Shimizu A, et al., Mann M, Lengyel E _medRxiv 2025.08.25.25333715_
  Integration of cell-type resolved spatial proteomics and
  transcriptomics reveals novel mechanisms including SUMOylation
  activation and ATR signaling.

- **NNMT Inhibition Restores Antitumor Immunity** Heide J, Bilecz AJ,
  et al., Mann M, \..., Lengyel E _Nature. 2025
  Sep;645(8082):1051-1059_ NNMT inhibitor reduces tumor burden by
  reprogramming cancer-associated fibroblasts and restoring immune
  checkpoint blockade efficacy.

- **3D Multi-omic Mapping of Fallopian Tubes (STIC)** Metousis A, et
  al., Mann M, Lengyel E _bioRxiv 2025.09.21.677628_ Spatially
  resolved multi-omics framework identifies 99 STICs and precursors in
  cancer-free organ donors, revealing high incidence of ovarian cancer
  precursors.

### Clinical Proteomics -- Nicolai Wewer Albrechtsen (Copenhagen)

- **ADAPT-MS Clinical Framework** Müller-Reif JB, Albrecht V, et al.,
  Wewer Albrechtsen NJ, Mann M _In press at Nature Communications_
  Adaptive diagnostic framework for clinical proteomics enabling
  personalized testing from plasma and CSF.

- **Benzon Symposium: Bridging Technology to Clinical Application**
  Albrecht V, Müller-Reif J, et al., Wewer Albrechtsen NJ, Mann M _Mol
  Cell Proteomics. 2024 Dec;23(12):100877_ Report on advances in
  clinical proteomics and translational strategies from the 68th
  Benzon Foundation Symposium.

### Other Key Collaborations

- **GPX4 and Ferroptosis in Neurodegeneration** Lorenz SM, et al.,
  Mann M, \..., Conrad M _Cell. 2025 Dec (with Marcus Conrad,
  Helmholtz Munich)_ A fin-loop-like structure in GPX4 underlies
  neuroprotection from ferroptosis. Proteomics revealed
  Alzheimer\'s-like signatures.

- **LRRK2 and Crohn\'s Disease/Colitis** Heaton GR, et al., Mann M,
  \..., Yue Z _J Clin Invest. 2025 Oct (with Zhenyu Yue, Mount Sinai)_
  Targeting specific LRRK2 kinase substrates rescues colitis severity
  caused by Crohn\'s disease-linked variant.

- **GID E3 Ligase Complex** Schulman lab with Mann lab proteomics
  _Multiple papers ongoing_ Continued collaboration on ubiquitin
  signaling including LRRC58/CDO1 cysteine availability studies.

## Clinical Impact Highlight

**JAK Inhibitors for Toxic Epidermal Necrolysis**

Our 2024 _Nature_ publication (Nordmann TM et al.) on spatial proteomics
identifying JAK inhibitors as treatment for toxic epidermal necrolysis
(TEN) -- a lethal skin disease -- has had immediate clinical impact in 2025. Off-label use of JAK inhibitors in the first patients worldwide
led to complete recovery.

_\"To our knowledge, this is the first time a spatial omics technology
has made an immediate and tangible impact in the clinic, by identifying
a treatment that has already changed people\'s lives for the good.\"_

--- Matthias Mann

## 2025 Preprints (bioRxiv/medRxiv)

- **SPEC workflow** Heymann et al. _bioRxiv May 2025_ Solid-Phase
  Extraction Capture for ultrasensitive proteomics

- **nanoPhos** Oliinyk et al. _bioRxiv May 2025_ Cell-type resolved
  spatial phosphoproteomics

- **Liver zonation** Weiss et al. _bioRxiv Apr 2025_ Single cell
  spatial proteomics of hepatocyte zonation

- **Tree-based proteoform quantification** Ammar et al. _bioRxiv Mar
  2025_ Inferring proteoform regulation from bottom-up data

- **ADAPT-MS** Müller-Reif et al. _medRxiv May 2025 (in press Nat
  Commun)_ Adaptive clinical diagnostics framework

- **scPortrait** Mädler et al. _bioRxiv Sep 2025_ Single-cell image
  integration for multimodal modeling

- **Early ovarian cancer (HGSC)** Metousis et al. _medRxiv Aug 2025_
  Spatial proteomics/transcriptomics integration

- **3D fallopian tube mapping (STIC)** Metousis et al. _bioRxiv Sep
  2025_ Multi-omic mapping revealing ovarian cancer precursors

- **Pre-analytical bias** Korff et al. _bioRxiv May 2025 (now
  published EMBO Mol Med)_ Bias in bead-enriched plasma proteomics

## Publication Summary by Journal

---

**Journal** **Count** **Topics**

---

_Nature_ 3 Liver disease (DVP), Review,
NNMT/CAFs (w/ Lengyel)

_Nature Biotechnology_ 1 AlphaDIA transfer learning

_Nature Genetics_ 1 Pediatric plasma proteome

_Nature Protocols_ 1 PASEF workflow

_Nature 1 ADAPT-MS (in press)
Communications_

_Cancer Cell_ 1 Ovarian cancer progression (w/
Lengyel)

_Cell_ 1 GPX4 ferroptosis (w/ Conrad)

_Cell Systems_ 1 Colon organoid DVP

_EMBO Mol Med_ 2 Rare pediatric disorders,
Pre-analytical bias

_Molecular Cell_ 1 Tumor-immune crosstalk

_Mol Cell Proteomics_ 2 PCA-N plasma, Stellar MS

_Commun Biol_ 1 Pancreatic islet cells

_NPJ Precision Oncol_ 1 Signet ring cell carcinoma

_Mol Syst Biol_ 1 AI laboratory agents

_J Clin Invest_ 1 LRRK2 colitis (w/ Yue)

---

For more information: [www.biochem.mpg.de/mann](https://www.biochem.mpg.de/mann)
